This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (418)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Lipids and Lipid Disorders  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic

A Comparison of C-Reactive Protein, Fibrinogen, Homocysteine, Lipoprotein(a), and Standard Cholesterol Screening as Predictors of Peripheral Arterial Disease

Paul M. Ridker, MD,MPH; Meir J. Stampfer, MD; Nader Rifai, PhD

JAMA. 2001;285:2481-2485.

Context  Several novel risk factors for atherosclerosis have recently been proposed, but few comparative data exist to guide clinical use of these emerging biomarkers.

Objective  To compare the predictive value of 11 lipid and nonlipid biomarkers as risk factors for development of symptomatic peripheral arterial disease (PAD).

Design, Setting, and Participants  Nested case-control study using plasma samples collected at baseline from a prospective cohort of 14 916 initially healthy US male physicians aged 40 to 84 years, of whom 140 subsequently developed symptomatic PAD (cases); 140 age- and smoking status–matched men who remained free of vascular disease during an average 9-year follow-up period were randomly selected as controls.

Main Outcome Measure  Incident PAD, as determined by baseline total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol–HDL-C ratio, triglycerides, homocysteine, C-reactive protein (CRP), lipoprotein(a), fibrinogen, and apolipoproteins (apo) A-I and B-100.

Results  In univariate analyses, plasma levels of total cholesterol (P<.001), LDL-C (P = .001), triglycerides (P = .001), apo B-100 (P = .001), fibrinogen (P = .02), CRP (P = .006), and the total cholesterol–HDL-C ratio (P<.001) were all significantly higher at baseline among men who subsequently developed PAD compared with those who did not, while levels of HDL-C (P = .009) and apo A-I (P = .05) were lower. Nonsignificant baseline elevations of lipoprotein(a) (P = .40) and homocysteine (P = .90) were observed. In multivariable analyses, the total cholesterol–HDL-C ratio was the strongest lipid predictor of risk (relative risk [RR] for those in the highest vs lowest quartile, 3.9; 95% confidence interval [CI], 1.7-8.6), while CRP was the strongest nonlipid predictor (RR for the highest vs lowest quartile, 2.8; 95% CI, 1.3-5.9). In assessing joint effects, addition of CRP to standard lipid screening significantly improved risk prediction models based on lipid screening alone (P<.001).

Conclusions  Of 11 atherothrombotic biomarkers assessed at baseline, the total cholesterol–HDL-C ratio and CRP were the strongest independent predictors of development of peripheral arterial disease. C-reactive protein provided additive prognostic information over standard lipid measures.

Author Affiliations: Center for Cardiovascular Disease Prevention (Drs Ridker and Rifai), Channing Laboratory (Dr Stampfer), and Leducq Center for Molecular and Genetic Epidemiology of Cardiovascular Disorders (Dr Ridker), Brigham and Women's Hospital, Harvard Medical School; Department of Epidemiology, Harvard School of Public Health (Dr Stampfer); and the Departments of Laboratory Medicine and Pathology, Children's Hospital Medical Center, Harvard Medical School (Dr Rifai), Boston, Mass.

RELATED ARTICLE

May 16, 2001
JAMA. 2001;285(19):2521-2522.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effects of Policosanol (10 mg/d) Versus Aspirin (100 mg/d) in Patients With Intermittent Claudication: A 10-Week, Randomized, Comparative Study
Illnait et al.
ANGIOLOGY 2008;59:269-277.
ABSTRACT  

Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study
Fornage et al.
Stroke 2008;39:1952-1959.
ABSTRACT | FULL TEXT  

Inflammatory Proteins and Muscle Strength in Adolescents: The AVENA Study
Ruiz et al.
Arch Pediatr Adolesc Med 2008;162:462-468.
ABSTRACT | FULL TEXT  

Effect of Psyllium Fiber Supplementation on C-Reactive Protein: The Trial to Reduce Inflammatory Markers (TRIM)
King et al.
Ann Fam Med 2008;6:100-106.
ABSTRACT | FULL TEXT  

Symptomatic Peripheral Arterial Disease in Women: Nontraditional Biomarkers of Elevated Risk
Pradhan et al.
Circulation 2008;117:823-831.
ABSTRACT | FULL TEXT  

Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Packard and Libby
Clin. Chem. 2008;54:24-38.
ABSTRACT | FULL TEXT  

A Prognostic Risk Index for Long-term Mortality in Patients With Peripheral Arterial Disease
Feringa et al.
Arch Intern Med 2007;167:2482-2489.
ABSTRACT | FULL TEXT  

Systemic Inflammation in Chronic Obstructive Pulmonary Disease: The Role of Exacerbations
Wouters et al.
Proc Am Thorac Soc 2007;4:626-634.
ABSTRACT | FULL TEXT  

Ankle brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort
Reich et al.
Vasc Med 2007;12:267-273.
ABSTRACT  

C-reactive Protein Level and Traditional Vascular Risk Factors in the Prediction of Carotid Stenosis
Mullenix et al.
Arch Surg 2007;142:1066-1071.
ABSTRACT | FULL TEXT  

Effect of Continuous Positive Airway Pressure Treatment on Serum Cardiovascular Risk Factors in Patients With Obstructive Sleep Apnea-Hypopnea Syndrome
Steiropoulos et al.
Chest 2007;132:843-851.
ABSTRACT | FULL TEXT  

Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease
Boehme et al.
Nephrol Dial Transplant 2007;22:2224-2229.
ABSTRACT | FULL TEXT  

Atherosclerosis in ANCA-Associated Vasculitides
PAGNOUX et al.
Ann. N. Y. Acad. Sci. 2007;1107:11-21.
ABSTRACT | FULL TEXT  

C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk: Moving an Inflammatory Hypothesis Toward Consensus
Ridker
J Am Coll Cardiol 2007;49:2129-2138.
ABSTRACT | FULL TEXT  

Biomarkers of Obesity and Subsequent Cardiovascular Events
Musaad and Haynes
Epidemiol Rev 2007;0:mxm005v1.
ABSTRACT | FULL TEXT  

Prognostic Significance of Brachial Flow-Mediated Vasodilation
Anderson
Circulation 2007;115:2373-2375.
FULL TEXT  

Endothelin-1 accentuates the proatherosclerotic effects associated with C-reactive protein
Ramzy et al.
J. Thorac. Cardiovasc. Surg. 2007;133:1137-1146.
ABSTRACT | FULL TEXT  

C-Reactive Protein Predicts Future Cardiovascular Events in Patients With Carotid Stenosis
Schlager et al.
Stroke 2007;38:1263-1268.
ABSTRACT | FULL TEXT  

C-reactive protein is elevated in the offspring of parents with essential hypertension
Jose Diaz et al.
Arch. Dis. Child. 2007;92:304-308.
ABSTRACT | FULL TEXT  

Rosuvastatin Affecting Aortic Valve Endothelium to Slow the Progression of Aortic Stenosis
Moura et al.
J Am Coll Cardiol 2007;49:554-561.
ABSTRACT | FULL TEXT  

Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study
Tzoulaki et al.
Eur Heart J 2007;28:354-362.
ABSTRACT | FULL TEXT  

Evaluation of the Effect of Neptune Krill Oil on Chronic Inflammation and Arthritic Symptoms
Deutsch
J. Am. Coll. Nutr. 2007;26:39-48.
ABSTRACT | FULL TEXT  

The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions
Dzau et al.
Circulation 2006;114:2871-2891.
FULL TEXT  

Genetic Variation Is Associated With C-Reactive Protein Levels in the Third National Health and Nutrition Examination Survey
Crawford et al.
Circulation 2006;114:2458-2465.
ABSTRACT | FULL TEXT  

C-Reactive Protein, Carotid Atherosclerosis, and Cerebral Small-Vessel Disease: Results of the Austrian Stroke Prevention Study
Schmidt et al.
Stroke 2006;37:2910-2916.
ABSTRACT | FULL TEXT  

Inflammation and Atherothrombosis: From Population Biology and Bench Research to Clinical Practice
Libby and Ridker
J Am Coll Cardiol 2006;48:A33-A46.
ABSTRACT | FULL TEXT  

Proteomics-based Development of Biomarkers in Cardiovascular Disease: Mechanistic, Clinical, and Therapeutic Insights
Mayr et al.
Mol. Cell. Proteomics 2006;5:1853-1864.
FULL TEXT  

Inflammatory markers and particulate air pollution: characterizing the pathway to disease
Zeka et al.
Int J Epidemiol 2006;35:1347-1354.
ABSTRACT | FULL TEXT  

Fenofibrate Reduces Atherogenesis in ApoE*3Leiden Mice: Evidence for Multiple Antiatherogenic Effects Besides Lowering Plasma Cholesterol
Kooistra et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:2322-2330.
ABSTRACT | FULL TEXT  

Statins and Cerebral Vasomotor Reactivity: Implications for a New Therapy?
Carod-Artal
Stroke 2006;37:2446-2448.
FULL TEXT  

The Effect of Novel Cardiovascular Risk Factors on the Ethnic-Specific Odds for Peripheral Arterial Disease in the Multi-Ethnic Study of Atherosclerosis (MESA)
Allison et al.
J Am Coll Cardiol 2006;48:1190-1197.
ABSTRACT | FULL TEXT  

Additive Value of Immunoassay-Measured Fibrinogen and High-Sensitivity C-Reactive Protein Levels for Predicting Incident Cardiovascular Events
Mora et al.
Circulation 2006;114:381-387.
ABSTRACT | FULL TEXT  

Pregnancy-Associated Plasma Protein-A Is Markedly Expressed by Monocyte-Macrophage Cells in Vulnerable and Ruptured Carotid Atherosclerotic Plaques: A Link Between Inflammation and Cerebrovascular Events
Sangiorgi et al.
J Am Coll Cardiol 2006;47:2201-2211.
ABSTRACT | FULL TEXT  

Risk Factors for Progression of Peripheral Arterial Disease in Large and Small Vessels
Aboyans et al.
Circulation 2006;113:2623-2629.
ABSTRACT | FULL TEXT  

Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases by PPAR-{alpha} Activators: Clinical and Experimental Evidence
Zambon et al.
Arterioscler. Thromb. Vasc. Bio. 2006;26:977-986.
ABSTRACT | FULL TEXT  

C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.
Tsimikas et al.
J Am Coll Cardiol 2006;47:C19-C31.
ABSTRACT | FULL TEXT  

Hemostatic Factors, Inflammatory Markers, and Progressive Peripheral Atherosclerosis: The Edinburgh Artery Study
Tzoulaki et al.
Am J Epidemiol 2006;163:334-341.
ABSTRACT | FULL TEXT  

Medical Treatment of Peripheral Arterial Disease
Hankey et al.
JAMA 2006;295:547-553.
ABSTRACT | FULL TEXT  

Production of Modified C-Reactive Protein in U937-Derived Macrophages
Ciubotaru et al.
Exp. Biol. Med. 2005;230:762-770.
ABSTRACT | FULL TEXT  

High-sensitivity C-reactive protein: potential adjunct for risk stratification in patients with stable congestive heart failure
Lamblin et al.
Eur Heart J 2005;26:2245-2250.
ABSTRACT | FULL TEXT  

Inflammatory Markers in Age-Related Maculopathy: Cross-sectional Analysis From the Muenster Aging and Retina Study
Dasch et al.
Arch Ophthalmol 2005;123:1501-1506.
ABSTRACT | FULL TEXT  

Cardiovascular Complications of Non-Steroidal Anti-Inflammatory Drugs
Fosslien
Annals of Clinical & Laboratory Science 2005;35:347-385.
ABSTRACT | FULL TEXT  

Assessment of Hemostatic Risk Factors in Predicting Arterial Thrombotic Events
Feinbloom and Bauer
Arterioscler. Thromb. Vasc. Bio. 2005;25:2043-2053.
ABSTRACT | FULL TEXT  

CRP is or is not a reliable marker of ischaemic heart disease?
Biasucci et al.
Lupus 2005;14:752-755.
ABSTRACT  

Relationship of Monocyte Count and Peripheral Arterial Disease: Results From the National Health and Nutrition Examination Survey 1999-2002
Nasir et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:1966-1971.
ABSTRACT | FULL TEXT  

C-Reactive Protein, Interleukin-6, and Soluble Adhesion Molecules as Predictors of Progressive Peripheral Atherosclerosis in the General Population: Edinburgh Artery Study
Tzoulaki et al.
Circulation 2005;112:976-983.
ABSTRACT | FULL TEXT  

C-Reactive Protein and Cerebral Small-Vessel Disease: The Rotterdam Scan Study
van Dijk et al.
Circulation 2005;112:900-905.
ABSTRACT | FULL TEXT  

Proapoptotic, Antimigratory, Antiproliferative, and Antiangiogenic Effects of Commercial C-Reactive Protein on Various Human Endothelial Cell Types In Vitro: Implications of Contaminating Presence of Sodium Azide in Commercial Preparation
Liu et al.
Circ. Res. 2005;97:135-143.
ABSTRACT | FULL TEXT  

Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome
Tarkun et al.
Eur J Endocrinol 2005;153:115-121.
ABSTRACT | FULL TEXT  

Review of Antiplatelet Therapy in Secondary Prevention of Cerebrovascular Events: A Need for Direct Comparisons Between Antiplatelet Agents
Jamieson et al.
J CARDIOVASC PHARMACOL THER 2005;10:153-161.
ABSTRACT  

Prognostic Impact of Fibrinogen in Carotid Atherosclerosis: Nonspecific Indicator of Inflammation or Independent Predictor of Disease Progression?
Sabeti et al.
Stroke 2005;36:1400-1404.
ABSTRACT | FULL TEXT  

C-Reactive Protein-Induced In Vitro Endothelial Cell Activation Is an Artefact Caused by Azide and Lipopolysaccharide
Taylor et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:1225-1230.
ABSTRACT | FULL TEXT  

Inflammation and Carotid Artery--Risk for Atherosclerosis Study (ICARAS)
Schillinger et al.
Circulation 2005;111:2203-2209.
ABSTRACT | FULL TEXT  

Lipid Response to a Low-Fat Diet with or without Soy Is Modified by C-Reactive Protein Status in Moderately Hypercholesterolemic Adults
Hilpert et al.
J. Nutr. 2005;135:1075-1079.
ABSTRACT | FULL TEXT  

Antiatherogenic potential of red wine: clinician update
Szmitko and Verma
Am. J. Physiol. Heart Circ. Physiol. 2005;288:H2023-H2030.
ABSTRACT | FULL TEXT  

Pathogenesis of Atherosclerosis
Crowther
ASH Education Book 2005;2005:436-441.
ABSTRACT | FULL TEXT  

CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Report From the Clinical Practice Discussion Group
Smith et al.
Circulation 2004;110:e550-e553.
FULL TEXT  

Relationship between Serum Lipoprotein Ratios and Insulin Resistance in Obesity
Brehm et al.
Clin. Chem. 2004;50:2316-2322.
ABSTRACT | FULL TEXT  

Endothelial Dysfunction in Young Women with Polycystic Ovary Syndrome: Relationship with Insulin Resistance and Low-Grade Chronic Inflammation
Tarkun et al.
J. Clin. Endocrinol. Metab. 2004;89:5592-5596.
ABSTRACT | FULL TEXT  

Vascular Remodeling in Atherosclerotic Femoral Arteries: Three-dimensional US Analysis
Gyongyosi et al.
Radiology 2004;233:366-375.
ABSTRACT | FULL TEXT  

Extracranial Thrombotically Active Carotid Plaque as a Risk Factor for Ischemic Stroke
Spagnoli et al.
JAMA 2004;292:1845-1852.
ABSTRACT | FULL TEXT  

Risk Stratification and Prognostic Implication of Plasma Biomarkers in Nondiabetic Patients With Stable Coronary Artery Disease: The Role of High-Sensitivity C-Reactive Protein
Leu et al.
Chest 2004;126:1032-1039.
ABSTRACT | FULL TEXT  

C-Reactive Protein Is Associated With Psychological Risk Factors of Cardiovascular Disease in Apparently Healthy Adults
Suarez
Psychosom. Med. 2004;66:684-691.
ABSTRACT | FULL TEXT  

Variation in the Lamin A/C Gene: Associations With Metabolic Syndrome
Steinle et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:1708-1713.
ABSTRACT | FULL TEXT  

Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999-2000
Selvin and Erlinger
Circulation 2004;110:738-743.
ABSTRACT | FULL TEXT  

Interpretation of observational studies
Jepsen et al.
Heart 2004;90:956-960.
FULL TEXT  

Apolipoprotein(a) Size and Lipoprotein(a) Concentration and Future Risk of Angina Pectoris with Evidence of Severe Coronary Atherosclerosis in Men: The Physicians' Health Study
Rifai et al.
Clin. Chem. 2004;50:1364-1371.
ABSTRACT | FULL TEXT  

Atherothrombosis: A widespread disease with unpredictable and life-threatening consequences
Viles-Gonzalez et al.
Eur Heart J 2004;25:1197-1207.
ABSTRACT | FULL TEXT  

C-Reactive Protein Increases Oxygen Radical Generation by Neutrophils
Prasad
J CARDIOVASC PHARMACOL THER 2004;9:203-209.
ABSTRACT  

Effects of Policosanol and Ticlopidine in Patients with Intermittent Claudication: A Double-Blinded Pilot Comparative Study
Castano et al.
ANGIOLOGY 2004;55:361-371.
ABSTRACT  

Association of Fear of Terror With Low-Grade Inflammation Among Apparently Healthy Employed Adults
Melamed et al.
Psychosom. Med. 2004;66:484-491.
ABSTRACT | FULL TEXT  

Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events
Ridker et al.
Circulation 2004;109:IV-6-IV-19.
FULL TEXT  

Atherosclerotic Vascular Disease Conference: Writing Group II: Risk Factors
Smith et al.
Circulation 2004;109:2613-2616.
FULL TEXT  

Atherosclerotic Vascular Disease Conference: Writing Group III: Pathophysiology
Faxon et al.
Circulation 2004;109:2617-2625.
FULL TEXT  

High-Density Lipoproteins Neutralize C-Reactive Protein Proinflammatory Activity
Wadham et al.
Circulation 2004;109:2116-2122.
ABSTRACT | FULL TEXT  

C-Reactive Protein Attenuates Endothelial Progenitor Cell Survival, Differentiation, and Function: Further Evidence of a Mechanistic Link Between C-Reactive Protein and Cardiovascular Disease
Verma et al.
Circulation 2004;109:2058-2067.
ABSTRACT | FULL TEXT  

C-Reactive Protein: Structure Affects Function
Verma et al.
Circulation 2004;109:1914-1917.
FULL TEXT  

Clinical Usefulness of Very High and Very Low Levels of C-Reactive Protein Across the Full Range of Framingham Risk Scores
Ridker and Cook
Circulation 2004;109:1955-1959.
ABSTRACT | FULL TEXT  

Global Suppression of IL-6-induced Acute Phase Response Gene Expression after Chronic in Vivo Treatment with the Peroxisome Proliferator-activated Receptor-{alpha} Activator Fenofibrate
Gervois et al.
J. Biol. Chem. 2004;279:16154-16160.
ABSTRACT | FULL TEXT  

Plasma C-Reactive Protein Concentrations in Active and Passive Smokers: Influence of Antioxidant Supplementation
Block et al.
J. Am. Coll. Nutr. 2004;23:141-147.
ABSTRACT | FULL TEXT  

Renal Insufficiency and the Risk of Lower Extremity Peripheral Arterial Disease: Results from the Heart and Estrogen/Progestin Replacement Study (HERS)
O'Hare et al.
J. Am. Soc. Nephrol. 2004;15:1046-1051.
ABSTRACT | FULL TEXT  

Treatment with oxandrolone and the durability of effects in older men
Schroeder et al.
J. Appl. Physiol. 2004;96:1055-1062.
ABSTRACT | FULL TEXT  

Relationship Between Intermittent Claudication, Inflammation, Thrombosis, and Recurrent Cardiac Events Among Survivors of Myocardial Infarction
Narins et al.
Arch Intern Med 2004;164:440-446.
ABSTRACT | FULL TEXT  

Women's Ischemic Syndrome Evaluation: Current Status and Future Research Directions: Report of the National Heart, Lung and Blood Institute Workshop: October 2-4, 2002: Section 5: Gender-Related Risk Factors for Ischemic Heart Disease
Shaw et al.
Circulation 2004;109 :e56-e58.
FULL TEXT  

Association Between C-Reactive Protein and Age-Related Macular Degeneration
Seddon et al.
JAMA 2004;291:704-710.
ABSTRACT | FULL TEXT  

Nontraditional Risk Factors for Cardiovascular Disease in Diabetes
Fonseca et al.
Endocr. Rev. 2004;25:153-175.
ABSTRACT | FULL TEXT  

Peroxisome Proliferator-Activated Receptor {gamma}: Implications for Cardiovascular Disease
Hsueh and Bruemmer
Hypertension 2004;43:297-305.
ABSTRACT | FULL TEXT  

Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion
Refsum et al.
Clin. Chem. 2004;50:3-32.
ABSTRACT | FULL TEXT  

Role of C-Reactive Protein in Cardiovascular Disease
Backes et al.
The Annals of Pharmacotherapy 2004;38:110-118.
ABSTRACT | FULL TEXT